GSK Crohn’s disease pill fails in Phase III
August 27, 2013Sales and Marketing GSK, vercirnon
A late-stage trial of GlaxoSmithKline’s investigational Crohn’s disease drug failed to benefit patients. The SHIELD-1 study was investigating vercirnon – …
Doctor questions FDA’s diet drug approvals
August 23, 2013Research and Development, Sales and Marketing BMJ, Belviq, EMA, FDA, Vivus, diet pills, obesity
Lilly drawn into China bribery scandal
August 22, 2013Medical Communications, Sales and Marketing China, GSK, Sanofi, bribery, corruption, lilly, payments
Merck told to make $1 billion in cuts
August 22, 2013Sales and Marketing Leerink Swann, MSD, Merck, Odanacatib, sugammadex
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
